Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1984
NEUROMUSCULAR EFFECTS OF HALOGENATED AGENTS IN PATIENTS WITH MYASTHENIA GRAVIS
Departments of Anesthesiology, Surgery, and Clinical Neurophysiology The Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York 10029
Anesthesiology September 1984, Vol. 61, A307.
Citation
J. B. Eisenkraft, A. E. Papatestas, M. Sivak; NEUROMUSCULAR EFFECTS OF HALOGENATED AGENTS IN PATIENTS WITH MYASTHENIA GRAVIS. Anesthesiology 1984; 61:A307 doi: https://doi.org/10.1097/00000542-198409001-00307
Download citation file:
Citing articles via
Most Viewed
Related Articles
Preanesthetic Train-of-four Fade Predicts the Atracurium Requirement of Myasthenia Gravis Patients
Anesthesiology (August 2000)
Severity of Myasthenia Gravis Influences the Relationship between Train-of-four Ratio and Twitch Tension and Run-down of Rat Endplate Potentials
Anesthesiology (February 2016)
Neuromuscular Monitoring at the Orbicularis Oculi May Overestimate the Blockade in Myasthenic Patients
Anesthesiology (November 2000)
Pharmacokinetic–Pharmacodynamic Modeling of Rocuronium in Case of a Decreased Number of Acetylcholine Receptors: A Study in Myasthenic Pigs
Anesthesiology (January 2003)
Foreign Body Aspiration: A Presenting Sign of Juvenile Myasthenia Gravis
Anesthesiology (August 2001)
